4.16
일부 수용체는 작용제가 최대 반응을 보이는 경우에도 비어 있는 상태로 유지됩니다. 이러한 빈 수용체를 예비 수용체라고 합니다. 여분의 수용체가 있는 경우 작용제 약물의 최대 효과는 수용체가 100% 미만으로 채워지는 경우에 달성됩니다. 예비 수용체의 존재를 확인하기 위…
일반적으로 작용제는 사용 가능한 전체 수용체 중 일부만 결합하여 최대 생물학적 반응을 생성합니다. 비어 있는 수용체는 예비 수용체(spare receptor)라고 합니다.
예비 수용체는 두 가지 메커니즘으로 인해 발생할 수 있습니다. 일부 경로에서는 하나의 작용제-수용체 복합체가 여러 중간 단백질 분자와 상호 작용하여 여러 효과기 분자를 활성화합니다. 따라서 수용체의 수가 사용 가능한 효과기 분자를 초과하여 많은 수용체가 남게 됩니다.
다른 경우에는, 작용제-수용체 복합체가 분해된 후에도 활성화된 중간 단백질이 효과기 단백질과 계속 상호 작용합니다. 결과적으로, 소수의 활성화된 수용체만이 최대한의 반응을 불러일으키기에 충분하고 나머지는 사용되지 않습니다.
이러한 메커니즘을 통해 세포는 호르몬 및 신경 전달 물질과 같은 저농도의 내인성 작용제를 사용하여 완전한 반응을 생성할 수 있습니다.
예를 들어, 인슐린 수용체의 99%는 여분입니다. 나머지는 낮은 인슐린 농도에서 활성화되어 혈당 수치를 하루 종일 유지합니다.
예비 수용체는 또한 큰 수용체 풀에서 약물-수용체 상호 작용 가능성이 증가함에 따라 작용제 약물에 대한 세포의 민감도를 증가시킵니다.
Q1: What are spare receptors and why do cells have them?
Spare receptors are unoccupied receptors that remain unused even when an agonist produces a maximal biological response. Cells maintain spare receptors as functional reserves, allowing them to economically use low concentrations of endogenous agonists such as hormones and neurotransmitters. This mechanism ensures cells can generate full responses without requiring all receptors to be activated, providing efficiency and sensitivity to signaling molecules.
Q2: How do spare receptors amplify cellular signals?
Spare receptors amplify signals through two mechanisms. First, a single agonist-receptor complex can activate multiple downstream effector proteins, so receptor numbers exceed available effector molecules. Second, activated effector molecules continue interacting with target proteins even after the agonist-receptor complex dissociates. These mechanisms allow only a fraction of receptors to produce maximal response, leaving the rest unused and available for signal amplification.
Q3: How is the presence of spare receptors detected experimentally?
Scientists detect spare receptors by comparing EC50 (drug concentration producing 50% maximum effect) with Kd (drug concentration occupying 50% of receptors). If EC50 is smaller than Kd, spare receptors are present. This comparison reveals that maximal effects occur with fewer than 100% of receptors occupied, indicating the existence of functional reserves that support signal amplification and cellular sensitivity.
Q4: Why do cells need higher antagonist concentrations when spare receptors are present?
When spare receptors are present, antagonists must occupy a larger proportion of total receptors to block agonist effects. For example, insulin receptors are 99% spare, so antagonists must occupy nearly all receptors to counteract insulin's response. In contrast, the heart has only 5-10% spare β-adrenoceptors, requiring lower antagonist concentrations. This relationship between spare receptor abundance and antagonist requirement reflects the functional reserve available for signal transduction.
Q5: How do spare insulin receptors maintain blood glucose homeostasis?
Approximately 99% of insulin receptors are spare, meaning only a small fraction of activated receptors are needed to allow glucose uptake and meet cellular energy requirements. This high proportion of spare receptors makes cells extremely sensitive to small changes in insulin concentration, enabling precise regulation of blood glucose levels around the clock. The spare receptors act as a buffer, ensuring consistent metabolic response despite fluctuating hormone levels.
Q6: What is the relationship between receptor occupancy and maximal biological response?
Maximal biological response does not require 100% receptor occupancy due to spare receptors and signal amplification mechanisms. One agonist-receptor complex can activate multiple effector molecules, and activated intermediary proteins continue signaling after the complex dissociates. This allows cells to achieve full response with partial receptor occupancy, demonstrating that biological efficacy depends on signal amplification rather than complete receptor saturation.
Q7: How do spare receptors increase cellular sensitivity to agonist drugs?
Spare receptors increase drug sensitivity by expanding the available receptor pool for drug-receptor interactions. With more unoccupied receptors present, the probability of drug molecules encountering and binding to receptors increases. This larger target pool makes cells more responsive to lower drug concentrations, enhancing the overall sensitivity of the cell to agonist drugs and allowing therapeutic effects at reduced doses.